サマリー

世界の真菌性角膜炎治療市場 2023-2027
真菌性角膜炎治療市場は、2022-2027年に1億8944万米ドルの成長が予測され、予測期間中のCAGRは4.39%で加速すると予測されます。当レポートでは、真菌性角膜炎治療市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、眼疾患に対する意識の高まり、真菌性角膜炎治療薬を販売するオンラインサイトの存在、眼科用新規ドラッグデリバリーシステムの技術革新の増加などが牽引しています。
Technavioの真菌性角膜炎治療薬市場は以下のように区分される：
投与経路別
- 経口
- 注射
- 局所投与
流通チャネル別
- 病院
- ドラッグストア
- その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間の真菌性角膜炎治療市場の成長を促進する主な理由の一つとして、眼科疾患に関する研究資金の増加を挙げている。また、真菌性角膜炎の治療のための新たなターゲットの出現や、非侵襲的な真菌性角膜炎検査に対する需要の高まりは、市場の大きな需要につながるでしょう。
真菌性角膜炎治療市場に関するレポートは以下の分野をカバーしています：
- 真菌性角膜炎治療市場のサイジング
- 真菌性角膜炎治療市場予測
- 真菌性角膜炎治療市場産業分析
本レポートでは、真菌性角膜炎治療薬市場の主要ベンダー（A.S. Lifesciences、Alvogen Iceland ehf、Aravind Eye Care System、Astellas Pharma Inc.、Bayer AG、Cipla Ltd.、Gilead Sciences Inc.、Glenmark Pharmaceuticals Ltd.、Goldfield Healthcare、Grevis Pharmaceuticals Pvt. Ltd.、ISKON REMEDIES and GMT、Merck and Co.Inc.、Novartis AG、Novo Holdings AS、Omicron Pharma、Pfizer Inc.Ltd.、Taj Pharmaceutical Ltd.、Viatris Inc.、Wellona Pharma。また、真菌性角膜炎治療市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/fungal-keratitis-treatment-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary €“ Chart on Market Overview
o Exhibit 02: Executive Summary €“ Data Table on Market Overview
o Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics
o Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary €“ Chart on Incremental Growth
o Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
o Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global fungal keratitis treatment market 2017 - 2021
o Exhibit 18: Historic Market Size €“ Data Table on global fungal keratitis treatment market 2017 - 2021 ($ million)
o 4.2 Route of Administration Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size €“ Route of Administration Segment 2017 - 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size €“ Distribution Channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Oral - Market size and forecast 2022-2027
o Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
o 6.4 Injection - Market size and forecast 2022-2027
o Exhibit 38: Chart on Injection - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Injection - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Injection - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Injection - Year-over-year growth 2022-2027 (%)
o 6.5 Topical - Market size and forecast 2022-2027
o Exhibit 42: Chart on Topical - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Topical - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Topical - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Route of Administration
o Exhibit 46: Market opportunity by Route of Administration ($ million)
o Exhibit 47: Data Table on Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 50: Chart on Comparison by Distribution Channel
o Exhibit 51: Data Table on Comparison by Distribution Channel
o 7.3 Hospitals - Market size and forecast 2022-2027
o Exhibit 52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
o 7.4 Drug stores - Market size and forecast 2022-2027
o Exhibit 56: Chart on Drug stores - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Drug stores - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Drug stores - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Drug stores - Year-over-year growth 2022-2027 (%)
o 7.5 Others - Market size and forecast 2022-2027
o Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 64: Market opportunity by Distribution Channel ($ million)
o Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 India - Market size and forecast 2022-2027
o Exhibit 103: Chart on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on India - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on India - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Alvogen Iceland ehf
o Exhibit 115: Alvogen Iceland ehf - Overview
o Exhibit 116: Alvogen Iceland ehf - Product / Service
o Exhibit 117: Alvogen Iceland ehf - Key offerings
o 12.4 Aravind Eye Care System
o Exhibit 118: Aravind Eye Care System - Overview
o Exhibit 119: Aravind Eye Care System - Product / Service
o Exhibit 120: Aravind Eye Care System - Key offerings
o 12.5 Astellas Pharma Inc.
o Exhibit 121: Astellas Pharma Inc. - Overview
o Exhibit 122: Astellas Pharma Inc. - Product / Service
o Exhibit 123: Astellas Pharma Inc. - Key news
o Exhibit 124: Astellas Pharma Inc. - Key offerings
o 12.6 Bayer AG
o Exhibit 125: Bayer AG - Overview
o Exhibit 126: Bayer AG - Business segments
o Exhibit 127: Bayer AG - Key news
o Exhibit 128: Bayer AG - Key offerings
o Exhibit 129: Bayer AG - Segment focus
o 12.7 Cipla Ltd.
o Exhibit 130: Cipla Ltd. - Overview
o Exhibit 131: Cipla Ltd. - Business segments
o Exhibit 132: Cipla Ltd. - Key news
o Exhibit 133: Cipla Ltd. - Key offerings
o Exhibit 134: Cipla Ltd. - Segment focus
o 12.8 Gilead Sciences Inc.
o Exhibit 135: Gilead Sciences Inc. - Overview
o Exhibit 136: Gilead Sciences Inc. - Product / Service
o Exhibit 137: Gilead Sciences Inc. - Key news
o Exhibit 138: Gilead Sciences Inc. - Key offerings
o 12.9 Glenmark Pharmaceuticals Ltd.
o Exhibit 139: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 140: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 141: Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.10 ISKON REMEDIES and GMT
o Exhibit 142: ISKON REMEDIES and GMT - Overview
o Exhibit 143: ISKON REMEDIES and GMT - Product / Service
o Exhibit 144: ISKON REMEDIES and GMT - Key offerings
o 12.11 Merck and Co. Inc.
o Exhibit 145: Merck and Co. Inc. - Overview
o Exhibit 146: Merck and Co. Inc. - Business segments
o Exhibit 147: Merck and Co. Inc. - Key news
o Exhibit 148: Merck and Co. Inc. - Key offerings
o Exhibit 149: Merck and Co. Inc. - Segment focus
o 12.12 Novartis AG
o Exhibit 150: Novartis AG - Overview
o Exhibit 151: Novartis AG - Business segments
o Exhibit 152: Novartis AG - Key offerings
o Exhibit 153: Novartis AG - Segment focus
o 12.13 Novo Holdings AS
o Exhibit 154: Novo Holdings AS - Overview
o Exhibit 155: Novo Holdings AS - Product / Service
o Exhibit 156: Novo Holdings AS - Key news
o Exhibit 157: Novo Holdings AS - Key offerings
o 12.14 Pfizer Inc.
o Exhibit 158: Pfizer Inc. - Overview
o Exhibit 159: Pfizer Inc. - Product / Service
o Exhibit 160: Pfizer Inc. - Key news
o Exhibit 161: Pfizer Inc. - Key offerings
o 12.15 Santen Pharmaceutical Co. Ltd.
o Exhibit 162: Santen Pharmaceutical Co. Ltd. - Overview
o Exhibit 163: Santen Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 164: Santen Pharmaceutical Co. Ltd. - Key offerings
o 12.16 Viatris Inc.
o Exhibit 165: Viatris Inc. - Overview
o Exhibit 166: Viatris Inc. - Business segments
o Exhibit 167: Viatris Inc. - Key news
o Exhibit 168: Viatris Inc. - Key offerings
o Exhibit 169: Viatris Inc. - Segment focus
o 12.17 Wellona Pharma
o Exhibit 170: Wellona Pharma - Overview
o Exhibit 171: Wellona Pharma - Product / Service
o Exhibit 172: Wellona Pharma - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 173: Inclusions checklist
o Exhibit 174: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 175: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 176: Research methodology
o Exhibit 177: Validation techniques employed for market sizing
o Exhibit 178: Information sources
o 13.5 List of abbreviations
o Exhibit 179: List of abbreviations


Exhibits:
Exhibits1: Executive Summary €“ Chart on Market Overview
Exhibits2: Executive Summary €“ Data Table on Market Overview
Exhibits3: Executive Summary €“ Chart on Global Market Characteristics
Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €“ Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary €“ Chart on Incremental Growth
Exhibits8: Executive Summary €“ Data Table on Incremental Growth
Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size €“ Data Table on global fungal keratitis treatment market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size €“ Route of Administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size €“ Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Injection - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Injection - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Injection - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Injection - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Topical - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Topical - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Route of Administration ($ million)
Exhibits47: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits49: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Drug stores - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Drug stores - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Drug stores - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Drug stores - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Distribution Channel ($ million)
Exhibits65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Alvogen Iceland ehf - Overview
Exhibits116: Alvogen Iceland ehf - Product / Service
Exhibits117: Alvogen Iceland ehf - Key offerings
Exhibits118: Aravind Eye Care System - Overview
Exhibits119: Aravind Eye Care System - Product / Service
Exhibits120: Aravind Eye Care System - Key offerings
Exhibits121: Astellas Pharma Inc. - Overview
Exhibits122: Astellas Pharma Inc. - Product / Service
Exhibits123: Astellas Pharma Inc. - Key news
Exhibits124: Astellas Pharma Inc. - Key offerings
Exhibits125: Bayer AG - Overview
Exhibits126: Bayer AG - Business segments
Exhibits127: Bayer AG - Key news
Exhibits128: Bayer AG - Key offerings
Exhibits129: Bayer AG - Segment focus
Exhibits130: Cipla Ltd. - Overview
Exhibits131: Cipla Ltd. - Business segments
Exhibits132: Cipla Ltd. - Key news
Exhibits133: Cipla Ltd. - Key offerings
Exhibits134: Cipla Ltd. - Segment focus
Exhibits135: Gilead Sciences Inc. - Overview
Exhibits136: Gilead Sciences Inc. - Product / Service
Exhibits137: Gilead Sciences Inc. - Key news
Exhibits138: Gilead Sciences Inc. - Key offerings
Exhibits139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits140: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits141: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits142: ISKON REMEDIES and GMT - Overview
Exhibits143: ISKON REMEDIES and GMT - Product / Service
Exhibits144: ISKON REMEDIES and GMT - Key offerings
Exhibits145: Merck and Co. Inc. - Overview
Exhibits146: Merck and Co. Inc. - Business segments
Exhibits147: Merck and Co. Inc. - Key news
Exhibits148: Merck and Co. Inc. - Key offerings
Exhibits149: Merck and Co. Inc. - Segment focus
Exhibits150: Novartis AG - Overview
Exhibits151: Novartis AG - Business segments
Exhibits152: Novartis AG - Key offerings
Exhibits153: Novartis AG - Segment focus
Exhibits154: Novo Holdings AS - Overview
Exhibits155: Novo Holdings AS - Product / Service
Exhibits156: Novo Holdings AS - Key news
Exhibits157: Novo Holdings AS - Key offerings
Exhibits158: Pfizer Inc. - Overview
Exhibits159: Pfizer Inc. - Product / Service
Exhibits160: Pfizer Inc. - Key news
Exhibits161: Pfizer Inc. - Key offerings
Exhibits162: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits163: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits164: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits165: Viatris Inc. - Overview
Exhibits166: Viatris Inc. - Business segments
Exhibits167: Viatris Inc. - Key news
Exhibits168: Viatris Inc. - Key offerings
Exhibits169: Viatris Inc. - Segment focus
Exhibits170: Wellona Pharma - Overview
Exhibits171: Wellona Pharma - Product / Service
Exhibits172: Wellona Pharma - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations